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Abstract
Objective: Acute organophosphorus(OP) pesticide poisoning is associated with dysfunctions in multiple organs, especially skel-
etal muscles, the nervous system and the heart. However, little is known about the specific microRNA (miRNA) changes that 
control the pathophysiological processes of  acute OP poisoning damage. We aimed to explore miRNA expression profiles and 
gain insight into molecular mechanisms of  OP toxic effects.
Methods: MicroRNA expression was analyzed by TaqMan Human MicroRNA Array analysis and subsequent validated with 
quantitive PCR. The targets of  the significantly different miRNAs were predicted with miRNA prediction databases, and path-
way analysis of  the predicted target genes was performed using bioinformatics resources.
Results: 37 miRNAs were significantly different in the sera of  poisoned patients compared to the healthy controls, including 
29 miRNAs that were up-regulated and 8 miRNAs that were down-regulated. Functional analysis indicated that many pathways 
potentially regulated by these miRNAs are involved in skeletal muscle, nervous system and heart disorders.
Conclusion: This study mapped changes in the serum miRNA expression profiles of  poisoning patients and predicted func-
tional links between miRNAs and their target genes in the regulation of  acute OP poisoning. Our findings are an important 
resource for further understanding the role of  these miRNAs in the regulation of  OP-induced injury.
Keywords: MicroRNA, expression profiles, human, acute organophosphorus pesticide poisoning, signaling pathways.
DOI: https://dx.doi.org/10.4314/ahs.v18i2.18
Cite as: Yuan H, Yuan M, Tang Y, Wang B, Zhan X. MicroRNA expression profiling in human acute organophosphorus poisoning and functional 
analysis of  dysregulated miRNAs. Afri Health Sci. 2018;18(2): 333-342. https://dx.doi.org/10.4314/ahs.v18i2.18
Introduction
Acute OP poisoning is a threat to human health world-
wide and causes significant morbidity and mortality, es-
pecially in developing countries. Patients exposed to 
these pesticides suffer from several health problems and 
deaths, mainly cholinergic system dysfunction, neurolog-
ical abnormalities, paralysis, muscle damage and cardiac 
abnormalities. However, further investigations are need-
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ed for understanding the pathophysiology of  the main 
target organ of  OP, and enable the development of  new 
therapies to reduce the mortality rate.
MicroRNAs (miRNAs) are small, non-protein coding 
RNA chains that are approximately 22 nucleotides in 
length. miRNAs modulate most cellular functions, in-
cluding cell differentiation, proliferation, migration, 
development, metabolism and apoptosis.1,2 According-
ly, small RNAs are critical regulators of  normal devel-
opment, physiology, pathology and organ damage and 
repair. Therefore, we deduced that miRNAs may play a 
crucial role in the pathophysiological processes of  acute 
OP poisoning.Recently, it is believed that the alterations 
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We hypothesised that circulating miRNA signatures may 
be used as a novel tool to study OP-induced injury. In the 
current study, we used a TaqMan Human MicroRNA Ar-
ray from Applied Biosystems to analyse the miRNA ex-
pression profiles of  serum samples obtained from acute 
OP poisoning patients compared to normal, healthy 
participants. 8 differentially expressed miRNAs were se-
lected for further validation using qRT-PCR. Then, we 
performed a preliminary analysis of  the Kyoto Encyclo-
pedia of  Genes and Genomes (KEGG) pathway for the 
potential target genes of  the most differentially expressed 
miRNAs. Our research provides information on the miR-




This study protocol was approved by the Human Eth-
ics Committees Review Board at the Second Affiliated 
Hospital of  the University of  South China (Hengyang, 
China), and written informed consent was obtained from 
all of  the participants prior to their enrollment.
A total of  34 individuals who were admitted to the emer-
gency department of  the Second Affiliated Hospital of  
the University of  South China with intentional oral OP(-
methamidophos) from October 2012 through Septem-
ber 2014 were selected and enrolled sequentially into the 
study as patient subjects (poisoning group). Their diag-
nosis was based on a history of  oral consumption of  or-
ganophosphorus pesticide methamidophos, the presence 
of  characteristic symptoms of  pesticide poisoning, and 
reduced blood acetylcholinesterase (AChE) activity. The 
durations of  the pesticide methamidophos ingestion to 
blood sample collection (at admission) were 3 hours to 24 
hours. The doses of  the ingested 50% methamidophos 
were from 20 ml to 40 ml. The blood AchE activity of  pa-
tients was decreased by 70% or more. The control group 
consisted of  30 healthy volunteer individuals recruited 
from the Health Screening Center of  the same hospital. 
The poisoning and control groups were matched by age 
and gender, and were from the same area, and lived and 
worked under comparable circumstances, and there was 
no past history of  exposure to toxic substances. Poten-
tial subjects who were diagnosed with diabetes mellitus, 
hypertension, hyperlipidaemia, inflammatory diseases, or 
malignant tumours during the clinical and laboratory ex-
aminations were excluded from this study.
Blood sampling
A peripheral venous blood sample (5 ml) was collected 
from each patient in the poisoning group at admission, 
and fasting venous blood samples were collected from 
healthy control subjects in the morning. The blood sam-
ples were centrifuged at 3000 r/min for 5 min, and then 
the sera were collected and saved at -20ºC, and used for 
miRNA analysis.
 
Total RNA extraction from subject samples
Total RNA was extracted from each serum sample using 
the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and 
purified using an Ambion mirVana miRNA Isolation Kit 
(Ambion, USA). This procedure efficiently recovered all 
RNA molecules, including miRNAs. The RNA quality 
and quantity were measured using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE, USA), and the RNA integrity was determined 
by gel electrophoresis.
 
TaqMan low-density array and RT-qPCR analysis
For microRNA array analysis, 3 randomly case samples 
and 3 randomly normal samples were selected. TaqMan 
Human MicroRNA A and B Arrays, version 3.0 (Applied 
Biosystems, Foster City, CA, USA) were used to screen 
the samples for the expression of  754 serum miRNAs 
on an ABI Prism 7900 HT Fast RealTime PCR system. 
To increase the sensitivity of  the TaqMan Low Densi-
ty Array, pre-amplification was performed after reverse 
transcribing the total RNA. The reverse transcription was 
performed using 500 ng of  total RNA, Megaplex™ RT 
Primers (Applied Biosystems, USA) and the TaqMan Mi-
croRNA Reverse Transcription Kit (Applied Biosystems, 
USA) to synthesise cDNA. The reaction mixtures were 
incubated at 16ºC for 2 min, at 42ºC for 1 min, and at 
85ºC for 5 min, and then they were cooled at 4ºC. Re-
al-time PCR was performed using TaqMan Universal 
PCR Master Mix II, No UNG (Applied Biosystems, USA) 
and a TaqMan Human MicroRNA Array Set, also from 
Applied Biosystems. The real-time PCR cycles consisted 
of  the UNG enzyme reaction at 50ºC for 2 min and a 
pre-denaturation cycle of  94.5ºC for 10 min, followed by 
40 cycles of  97ºC for 30 sec and 59.7ºC for 1 min. All 
reactions were performed as specified in the manufac-
turer’s protocol. The miRNA expression was calculated 
based on the cycle threshold (Ct) values and normalised 
to U6 snRNA and RNU44. The assays were completed in 
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triplicate. Amplification signals were computed with 7500 
software v2.0.6 (Applied Biosystems, USA). The relative 
miRNA expression levels were calculated by the 2-ΔΔCt 
method.
 
Selection of  miRNA candidates
After the TaqMan low-density array and RT-qPCR anal-
ysis, the expression of  an individual miRNA was defined 
as being significantly different from the compared groups 
if  the P-value was < 0.05 and the fold change was more 
than 2.
 
Validation of  expressed miRNAs by qRT-PCR anal-
ysis
To validate the miRNA array results in our study, four 
randomly up-regulated miRNAs (miR-29b, miR-133a, 
miR-214 and miR-590) and four down-regulated miR-
NAs(miR-125b, miR-141-5p, miR-150 and miR-642a) 
were selected for further qRT-PCR confirmation with 
all samples of  poisoning group and control group. The 
methodological details of  qRT-PCR and internal control 
(cel-miR-39) were as previously described.4  The miRNAs 
were reversely transcribed into cDNAs by using the Re-
verTra Ace qPCR RT Kit (TOYOBO, Japan). The qPCR 
then conducted using the SYBR Premix Ex TaqTM kit 
(TakaRa, Dalian, China). qRT-PCR was processed in 96-
well plates on a 7500HT analyzer (Applied Biosystems, 
USA) according to the direction of  the reagents in trip-
licate. The sequence-specific RT primers and the qPCR 
primers are shown in Table 1, which was provided by 
GenePharma (Shanghai, China). The threshold cycle (Ct) 
values used in the calculation were the means of  the trip-
licates. The relative expression of  each miRNA was nor-
malized using the Ct obtained from internal control using 
the 2-ΔΔCt method.
miRNA target gene prediction and pathway analysis
The identification of  targets of  miRNAs is crucial for 
elucidating their function. However, the miRNA-target 
interaction is very complicated. At present, several tar-
get prediction algorithms have been developed, but they 
show poor overlap in their outputs, suggesting that they 
generate many false-positive and false-negative predic-
tions.5 Here, putative target genes of  miRNAs were pre-
dicted using two miRNA databases: TargetScan (http://
www.targetscan.org/) and miRDB (http://mirdb.org/
miRDB/index.html). We compared the predicted target 
genes from both algorithms and selected the predicted 
targets that were identified by both databases. We con-
ducted the analyses separately for the up-regulated and 
down-regulated miRNAs.
For pathway analysis of  the predicted targets, the KEGG 
pathway analysis, which is a systematic analysis of  gene 
functions in terms of  the networks of  genes and mol-
ecules, was conducted on the predicted target genes to 
identify their associated signalling pathways. KEGG 
pathway analysis was carried out using DAVID Bioinfor-
matics Resources 6.7 (http://david.abcc.ncifcrf.gov/).
 
Statistical analysis
Statistical testing was conducted with the assistance of  
the SPSS 13.0 software. An independent-samples t-test 
was performed to determine which miRNAs were modu-
lated at a significant level (P < 0.05). The P value was ad-
justed by Bonferroni correction to counteract the prob-




The TaqMan Human MicroRNA Array showed 232 miR-
NAs that were expressed in the sera of  the patients and 
the healthy controls at different levels. Compared to the 
normal samples, 37 miRNAs were significantly altered in 
the sera of  the patients, including 29 miRNAs that were 
up-regulated and 8 miRNAs that were down-regulated 
(Table 2).
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Table 1 qRT-PCR primer sequences of 8 miRNAs 
 
miRNA Primer sequences 
miR-29b RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACACTG-3’ 
  Forward primer: 5’-GGCGAGCTAGCACCATTTGAAAT-3’ 
miR-133a RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCAGCTG-3’ 
  Forward primer: 5’-AGAGGATTTGGTCCCCTTCAAC-3’ 
miR-214 RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACTGCCT-3’ 
  Forward primer: 5’-TTTGTTGACAGCAGGCACAGAC-3’ 
miR-590 RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTGCACT-3’ 
  Forward primer: 5’-CGGCGGCGAGCTTATTCATAAA-3’ 
miR-125b RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCACTTG-3’ 
  Forward primer: 5’- AGTAGGTGTTCCCTGAGACCCTAA-3’ 
miR-141-5p RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCATCTT-3’ 
  Forward primer: 5’-GGCCACGATAACACTGTCTGGTA-3’ 
miR-150 RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACTGG-3’ 
  Forward primer: 5’-GAGGTAGGATCTCCCAACCCTTGTA-3’ 
miR-642a RT primer: 5’-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCAAGAC-3’ 
  Forward primer: 5’-GAGAGTAGGTCCCTCTCCAAATGT-3’ 
All miRNAs Common reverse primer: 5’- TCCAGTGCAGGGTCCGAGGT-3’ 
  
Table 2 Differential expression of 37 microRNAs in the sera of 




P-value Regulation Name Fold 
change 
P-value Regulation 
miR-133a 75.889 0.032 Up miR-561 3.128 0.010 Up 
miR-599 31.833 0.004 Up miR-1267 3.127 0.006 Up 
miR-135a 10.237 0.009 Up miR-590-5p 3.075 0.038 Up 
miR-545 8.989 0.018 Up miR-375 2.857 0.047 Up 
miR-661 7.852 0.000 Up miR-1290 2.719 0.004 Up 
miR-138 6.709 0.019 Up miR-454 2.697 0.046 Up 
miR-623 6.359 0.015 Up miR-625-3p 2.611 0.037 Up 
miR-515-3p 5.639 0.001 Up miR-126 2.573 0.005 Up 
miR-590-3p 5.328 0.048 Up miR-28-5p 2.011 0.008 Up 
miR-362 5.010 0.000 Up miR-27a-5p 2.005 0.000 Up 
miR-194 4.485 0.022 Up miR-155 -2.006 0.001 Down 
miR-1291 4.265 0.000 Up miR-122 -2.110 0.000 Down 
miR-29b 4.146 0.000 Up miR-193b -2.321 0.000 Down 
let-7g 4.087 0.000 Up miR-642a -2.342 0.000 Down 
miR-142-3p 4.068 0.027 Up miR-141-5p -2.849 0.001 Down 
miR-192 3.821 0.033 Up miR-125b -3.215 0.001 Down 
miR-223 3.625 0.000 Up miR-301 -4.065 0.005 Down 
miR-483-5p 3.563 0.007 Up miR-150 -5.319 0.006 Down 
miR-214 3.519 0.011 Up         
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miRNAs that were differentially expressed in the AOPP 
group and the control group. Candidate miRNAs exhib-
ited a greater than 2-fold difference, P < 0.05. miRNAs 
described as “up” are higher in the AOPP patients than 
in the healthy controls, whereas “down” indicates lower 
expression in the AOPP group than in the control group.
To verify the accuracy of  array results, 8 randomly miR-
NAs (miR-29b, miR-133a, miR-214, miR-590, miR-125b, 
miR-141-5p, miR-150 and miR-642a) were selected for 
further qRT-PCR analysis with all patients and controls. 
The results were comparable with the array results (Fig-
ure 1).
 
Figure 1. The expression of selected miRNAs were validated by qRT-PCR. 
Compared to the control group(control), the expression 
of  miR-29b, miR-133a, miR-214,and miR-590 in poi-
soning group(OP) were significantly higher, while the 
expressions miR-125b, miR-141-5p, miR-150, and miR-
642a in poisioning group(OP) were significantly lower (* 
P <0.05).
 
KEGG pathways associated with the differentially 
expressed target genes
The target genes of  the differentially expressed miRNAs 
were predicted. In total, 2290 and 374 target genes were 
up-regulated and down-regulated by miRNAs, respective-
ly. To understand the functions of  the two types of  genes, 
we utilised KEGG pathway analysis with DAVID Bioin-
formatics Resources. The major component of  KEGG 
is the PATHWAY database that consists of  graphical di-
agrams of  biochemical pathways, including most of  the 
known metabolic pathways and some of  the known reg-
ulatory pathways. The KEGG enrichment analysis path-
ways, which contained many of  the significantly differ-
entially expressed target genes (P < 0.05), were identified 
in the up-regulated and down-regulated miRNA groups, 
respectively. In total, 29 KEGG pathways were overrep-
resented among the target genes in the up-regulated miR-
NA group, and they are shown in Table 3. Among these 
pathways are “axon guidance”, “ErbB signalling path-
way”, and “long-term potentiation”, etc. Moreover, two 
KEGG pathways were significantly represented among 
the target genes in the down-regulated miRNAs group, 
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Table 3. Overrepresented KEGG pathways among the 
target genes of the up-regulated miRNAs 
 
KEGG pathway Term Number 
of Genes 
hsa04360:Axon guidance 36 
hsa04012:ErbB pathway 27 
hsa04720:Long-term potentiation 22 
hsa05214:Glioma 20 
hsa05200:Pathways in cancer 64 
hsa04722:Neurotrophin signalling pathway 31 
hsa04810:Regulation of actin cytoskeleton 46 
hsa05218:Melanoma 21 
hsa04910:Insulin signalling pathway 32 
hsa04010:MAPK signalling pathway 53 
hsa04310:Wnt signalling pathway 34 
hsa04350:TGF-beta signalling pathway 23 
hsa04510:Focal adhesion 41 
hsa05220:Chronic myeloid leukaemia 20 
hsa04144:Endocytosis 37 
hsa04916:Melanogenesis 23 
hsa05215:Prostate cancer 21 
hsa05210:Colorectal cancer 20 
hsa04912:GnRH signalling pathway 22 
hsa04730:Long-term depression 17 
hsa04540:Gap junction 20 
hsa04120:Ubiquitin-mediated proteolysis 27 
hsa04530:Tight junction 26 
hsa05211:Renal cell carcinoma 16 
hsa04520:Adherens junction 17 
hsa04020:Calcium signalling pathway 32 
hsa05414:Dilated cardiomyopathy 19 
hsa04130:SNARE interactions in vesicular transport 10 
hsa04512:ECM-receptor interaction 17 
 
Discussion
Acute OP poisoning has became a major public health 
problem with more than 300,000 deaths each year around 
the world,6 most commonly due to organophosphorus, 
and China has one of  the highest morbidity and mor-
tality rates from OP poisoning. It is also known to cause 
suicide, homicide, and non-intentional and occupation-
al poisonings. In China, as in other developing countries 
that lack surveillance systems, regulation, enforcement, 
training, access to information systems, and well-main-
tained personal protective equipment and that have large 
agriculturally based populations, the incidence is very 
high. Acute OP poisoning can cause serious health prob-
lems, especially neuropathy, muscular damage and cardi-
ac dysfunction. However, the mechanisms for many of  
these pathophysiologies are unclear.
miRNAs have been widely studied in recent years because 
they play a critical role in the pathogenesis of  diverse dis-
eases. miRNAs are remarkably stable and can be readily 
quantified in human and animal sera and plasma. More 
importantly, circulating miRNAs demonstrate significant 
dynamic change under some pathological conditions and 
can partially reflect tissue damage.7,8 Circulating miRNAs 
play an important role in the pathogenesis of  many dis-
eases.
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Recently, a study of  zebrafish indicates that 14 miRNAs 
were differentially expressed ascribable to the treatments 
with fipronil, triazophos and their mixture.9 However, a 
role for miRNA in human acute OP poisoning has not 
been reported, and little is known about the miRNA net-
works that control pathophysiological processes in the 
patients. In this study, we used a genome-wide TaqMan 
low-density array technology to determine the serum 
miRNA expression levels in three randomly patients and 
three randomly healthy controls to identify biomarkers of  
tissue damage and to improve our understanding of  this 
disease. Then we verified the expressions of  miRNAs us-
ing qRT-PCR with all patients and controls. Interestingly, 
we also successfully identified a set of  differentially ex-
pressed miRNAs between the poisoning patients and the 
healthy controls. Overall, by TaqMan low-density array 
analysis, 37 miRNAs were markedly altered in the sera of  
patients compared to the healthy controls, including 29 
miRNAs that were up-regulated and 8 miRNAs that were 
down-regulated. Then, 4 up-regulated and 4 down-regu-
lated miRNAs were selected for verification. We found 
results of  qRT-PCR and array analysis correlated strong-
ly. Thus, it appears that poisoning with methamidophos 
causes specific changes in human serum miRNA.  The-
expression profiling may be useful for in-depth research 
into OP-induced injury. To date, no reports are available 
on the effect of  organophosphorus poisoning on these 
miRNAs of  the.
Organophosphorus compounds exert acute systemic 
toxicity through phosphorylation by inhibiting the en-
zyme acetylcholinesterase, thus causing acute neurotox-
icity. Nervous system damage is the most common tox-
ic effect of  acute OP poisoning.10 The dysregulation of  
miRNAs may contribute to OP-induced neuropathies. 
We conducted a systematic literature review of  studies 
on peripheral neuropathy-related miRNAs and found 
many studies on miRNAs and nervous system damage 
diseases. For example, recently, a few studies have indicat-
ed that in the pathogenesis of  nervous system diseases, 
miR-29b,11 miR-138,12 and miR-15513 play an important 
role. Schwann cells are the principle glia of  the peripheral 
nervous system (PNS). They function to support neu-
rons, and many neuropathies involve Schwann cells. A 
recent study of  sciatic nerve injury in mice indicated that 
a cohort of  22 miRNAs coordinates Schwann cell dif-
ferentiation and de-differentiation through combinatorial 
modulation of  their positive and negative gene regula-
tors. miR-138 and miR-709 show the highest likelihood 
of  regulating Egr2, Sox-2 and c-Jun expression following 
injury.12 Furthermore, Verrier et al. showed that miR-29a 
binds and inhibits PMP22 reporter expression through a 
specific miRNA seed-binding region.11 Peripheral myelin 
protein 22 (PMP22) is a dose-sensitive, disease-associated 
protein primarily expressed in myelinating Schwann cells. 
The over-expression of  miR-29a enhances the associa-
tion of  PMP22 RNA with Argonaut 2, a protein involved 
in miRNA function, and it reduces the steady-state levels 
of  PMP22, which plays an important role in Schwann 
cell injury. In contrast to miR-29a, miR-29b expression 
was significantly increased in the OP poisoning patients; 
in fact, both miR-29a and miR-29b belong to the same 
miR-29 family.
Another disease in which these miRNAs have been found 
is Guillain-Barré syndrome (GBS), which is an acute 
polyneuropathy disorder affecting the peripheral nervous 
system. Wang et al. showed that miR-155 is down-regulat-
ed in peripheral blood mononuclear cells (PBMCs) from 
GBS patients and that silencing miR-155 profoundly pro-
motes the production of  Th1-type cytokines in vitro.13 
Interestingly, delayed onset distal polyneuropathy is a 
consequence of  severe intoxication due to the inhibition 
of  the neuropathy target esterase (NTE) enzyme,14 also 
known as patatin-like phospholipase domain-contain-
ing 6 (PNPLA6), in nervous tissues by certain organo-
phosphorous compounds. Interestingly, we found that 
the PNPLA6 gene was targeted by miR-214 and miR-
454 from the TargetScan database, and both miRNAs 
were up-regulated in our study. Whether or not miR-214 
and miR-454 participate in the formation of  epigenetic 
silencing complexes with PNPLA6 mRNA to induce-
post-transcriptional gene silencing has not been reported; 
however, these data suggest that miR-214 and miR-454 
may control the translation of  PNPLA6 to contribute to 
delayed polyneuropathy. The significant changes in these 
miRNAs demonstrate that they may be novel biomarkers 
for OP-induced nervous system damage.
The paralysis of  muscles and muscular damage are com-
mon in OP poisoning patients. Many studies have re-
ported that deregulated miR-29b,15 miR-125b,12 miR-
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133a,16-18 miR-135,19 miR-155,18 miR-193b,12 miR-22318,19 
and miR-36218 were connected with the pathogenesis 
of  muscular diseases. Kornfeld et al. showed increased 
miR-29b transcription in the pectoral muscle of  torpid 
bats.15 Endo et al. reported that miR-133a is a muscle-re-
lated miRNA, and deregulated miR-133a plays central 
regulatory roles in muscle disease.16 Interestingly, another 
study noted up-regulated miR-133a in the skeletal mus-
cle of  mdx mice, an animal model for human muscular 
dystrophy.17 Furthermore, in facioscapulohumeral mus-
cular dystrophy (FSHD), another hereditary neuromus-
culardisorder, 29 miRNAs were found to be differentially 
expressed between FSHD and normal myoblasts, includ-
ing miR-133a, miR-223 and miR-362, which were up-reg-
ulated, and miR-155, which was down-regulated.18 In fact, 
miR-133a is the most profoundly different miRNA on 
our list, and it may be one of  the most important miR-
NAs in acute OP poisoning. Additionally, a degenerative 
miRNA, miR-135a, and an inflammatory miRNA, miR-
223, are involved in the pathological pathways activated 
in skeletal muscle damage and regeneration by both dys-
trophin absence and acute ischaemia in MDX mice and 
in DMD patients.19 Furthermore, in Myotonic Dystrophy 
Type-2 (DM2), an autosomal dominant disease that main-
ly affects skeletal muscles, the heart and the central ner-
vous system, many miRNAs are deregulated, and miR-
125b and miR-193b are decreased.12 Therefore, altered 
miRNAs are responsible for muscle diseases. Interest-
ingly, we observed that many days after their poisoning, 
many acute OP poisoning patients showed varying de-
grees of  muscular weakness and atrophy. These symp-
toms are similar to those of  the aforementioned muscular 
diseases, but currently there is no reasonable explanation 
for this similarity. We speculate that OP-induced muscu-
lar damage is related to these dysregulated miRNAs.
Cardiac complications accompany poisoning with or-
ganophosphates are extremely common, these compli-
cations may be serious and are often fatal and include 
electrocardiographic abnormalities, conduction defects, 
cardiac arrhythmias, cardiac troponin T (cTnT) and myo-
cardial enzyme elevation, and myocardial infarction and 
failure, a series of  complications that is attracting substan-
tial attention. Nevertheless, the pathogenesis of  cardiac 
toxicity from these compounds is not yet clearly defined. 
Careful electrocardiographic and enzymatic monitoring 
and cardiac complication treatment are necessary for 
organophosphate poisoning in all patients. Heart dam-
age and electrocardiographic abnormalities are connect-
ed with many miRNAs, such as up-regulated miR-29b,20 
miR-126,21 miR-133a,22 miR-142-3p23, miR-19224, miR-
19424, and miR-590-5p25 and down-regulated miR-12226, 
miR-125b26 and miR-15527. All of  these studies suggest 
that OP may impair cardiac health by altering miRNA 
expression. However, precisely how altered expression of  
these miRNAs affects cardiac complications needs clari-
fication.
To investigate the function and intracellular signalling 
pathways of  the two types of  miRNAs in acute OP poi-
soning, we predicted the target genes of  different miR-
NAs using two miRNA prediction databases (TargetS-
can and miRDB ), and we generated lists of  2290 and 
374 potential gene targets of  up-regulated miRNAs and 
down-regulated miRNAs, respectively. Then, we analysed 
the target genes with the KEGG pathway database, and 
we found that 29 KEGG pathways were overrepresented 
among the target genes in the up-regulated miRNA group, 
mainly axon guidance, long-term potentiation, the neuro-
trophin signalling pathway, the insulin signalling pathway, 
SNARE interactions in vesicular transport, the regulation 
of  the actin cytoskeleton, the calcium signalling pathway, 
dilated cardiomyopathy, endocytosis, focal adhesion, gap 
junctions, tight junctions, adherens junctions, the ErbB 
signalling pathway, the MAPK signalling pathway, the 
Wnt signalling pathway, the TGF-beta signalling pathway, 
ECM-receptor interaction and ubiquitin mediated pro-
teolysis (Table 3). The target genes of  down-regulated 
miRNAs were involved in the mTOR signalling pathway 
and the ubiquitin mediated proteolysis. To our surprise, 
our target prediction analysis also revealed that miRNAs 
identified in our experiment and their target genes are as-
sociated with a number of  pathophysiological pathways 
that could indirectly influence multiple organ dysfunc-
tions, especially muscular, nervous and heart disorders. 
Knowing that  these miRNAs might play an important 
role in OP-induced damage.
Conclusion 
Although there is no evidence presented for a causal rela-
tionship between one or more specific miRNAs and any 
of  the adverse effects of  methamidophos, our study lays 
the groundwork for further molecular studies to identi-
fy the novel deregulated miRNAs potentially involved in 
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OP toxicity, and it provides insight into the pathways that 
are damaged in acute OP poisoning. These data will be 
central to understanding how complications develop and 
the molecular mechanisms of  OP-induced injury. How-
ever, to understand how these dysregulated miRNAs and 
their targets interact with acute OP poisoning, further 
sample neural, muscular, heart, and liver biopsies from 
their cohorts to examine the mRNA profling and miR-
NA changes directly in the affected tissues are required. 
Manipulating the expression of  these miRNAs may pro-
mote understanding of  the underlying mechanisms that 
are critical for OP-induced damage and ultimately pro-
vide therapeutic benefits for monitoring, preventing and 
treating OP poisoning complications and concomitant 
pathological lesions.
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